Newfeed

SEONGNAM, South Korea and ATLANTA, March 28, 2024 /PRNewswire/ — Bridge Biotherapeutics (KQ288330), a South Korean clinical-stage biotech company developing novel drugs for cancer, fibrosis, and inflammation, announced a research collaboration with Dr. Jessica M. Konen’s Lab at Emory U

Magazine made for you.

Featured:

No posts were found for provided query parameters.

Elsewhere: